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Abstract
Otitismedia (OM), the inﬂammation of themiddle ear, is themost commondisease and cause for surgery in infantsworldwide.
Chronic Otitis media with effusion (OME) often leads to conductive hearing loss and is a common feature of a number of
craniofacial syndromes, such as 22q11.2 Deletion Syndrome (22q11.2DS). OM is more common in children because the more
horizontal position of the Eustachian tube (ET) in infants limits or delays clearance ofmiddle ear effusions. Somemousemodels
with OM have shown alterations in the morphology and angle of the ET. Here, we present a novel mechanism in which OM is
caused not by a defect in the ET itself but in themuscles that control its function. Our results show that in twomousemodels of
22q11.2DS (Df1/+ and Tbx1+/−) presenting with bi- or unilateral OME, the fourth pharyngeal arch-derived levator veli palatini
muscles were hypoplastic, which was associated with an earlier altered pattern ofMyoD expression. Importantly, in mice with
unilateral OME, the side with the inﬂammation was associated with signiﬁcantly smaller muscles than the contralateral
unaffected ear. Functional tests examining ET patency conﬁrmed a reduced clearing ability in the heterozygous mice. Our
ﬁndings are also of clinical relevance as targeting hypoplasticmusclesmight present a novel preventativemeasure for reducing
the high rates of OM in 22q11.2DS patients.
Introduction
DiGeorge syndrome, conotruncal anomaly face syndrome and
Velo-Cardio-Facial Syndrome are caused by a deletion of a 1.5-
to 3 Mb fragment of human chromosome 22q11.2 and as such
are commonly referred to as 22q11.2 Deletion Syndrome
(22q11.2DS, OMIM #188400) (1). 22q11.2DS is the most common
congenital microdeletion syndrome in humans, occurring at a
frequency of 1 in 4000 live births, with 5–10% of cases inherited
(2,3). Most patients (95%) present with an interstitial deletion en-
compassing 3 Mb, known as the typically deleted region inwhich
∼30 genes have been mapped (4). However, smaller deletions
(1.5–2 Mb) and unbalanced translocations between chromosome
15 and 22 have also been identiﬁed as causing 22q11.2DS mani-
festations (5,6).
22q11.2DS patients suffer from a wide and phenotypically
varied spectrum of anomalies, including palatal anomalies
(69–100%) such as submucosal and hard palate clefts (3), velo-
pharyngeal insufﬁciency, thymus gland hypoplasia, parathyroid
abnormalities, malformations of the cardiovascular system and
skeletal muscle hypotonia (7). All thesemalformations can be at-
tributed to developmental defects of the pharyngeal apparatus
(3,8–10). Interestingly, the condition is also associated with high
frequencies (80–100%) of neurocognitive disabilities (11) and
hearing impairment (12).
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22q11.2DS patients frequently display conductive (45–84%),
sensorineural (11–15%) or mixed (5%) hearing loss, with conduct-
ive hearing loss mainly being attributed to inﬂammation of the
middle ear cavity, known as Otitis media (OM) (12). Hearing
impairment from early ages can alter behaviour, interfere with
the process of speech and language development and lead to
learning disabilities. Therefore, early audiological assessment
of 22q11.2DS patients and therapy for recurrent episodes of OM
is highly recommended (13–15).
OM, in general, is the most common disease in young chil-
dren worldwide, occurring at least once before the age of 2 in
90% of infants in the developed world (16). The disease is typic-
ally classiﬁed as either acute or chronic. Acute OM is commonly
associated with a viral or bacterial infection and often resolves
spontaneously (17). Otitis media with effusion (OME) is charac-
terized by hyperplasia of the middle ear mucosa, excessive ser-
ous ormucoid secretions that accumulate in theMEC. In chronic
forms of OME, the effusion is inﬁltrated by inﬂammatory cells
(18). Excessive exudate often leads to conductive hearing loss
by the obstruction of middle ear ossicle movement. In severe
cases of the disease, OM can be accompanied by tympanic
membrane perforation (chronic suppurative OM) and perman-
ent conductive hearing loss owing to ossicle remodelling
(19,20). More than 50% of 22q11.2DS patients under the age of
7 display recurrent episodes of OM (21,22). Risk factors for OM
are various, including bacterial infections, altered immune sta-
tus, exposure to tobacco smoke, poor mucociliary clearance and
craniofacial abnormalities such as cleft palate and Eustachian
tube (ET) dysfunction (22–25). The ET connects the middle ear
cavity to the nasopharynx and normally functions to clear se-
cretions from the ear and to equalize middle ear pressure
(26,27). Predisposing factors for OM include either a persistently
open (patent) or closed ET, variation in length and more hori-
zontal angles, as observed in children under the age of 2,
as well as blockage or altered positions of the ET, either pro-
voked by abnormal tissue growth or craniofacial defects such
as cleft palates (28–31). In addition to the multifactorial patho-
genesis of OM, a role for genetic predisposition is increasingly
recognized (32).
As human approaches are limited, murine animal models
have been engineered to study the diverse pathobiology of
22q11.2DS. One of these mouse models is the hemizygous Df1
(deﬁciency 1)-knockout mouse (Df1/+), which carries a multi-
gene deletion in a region of mouse chromosome 16 that is hom-
ologous to the 22q11.2 region in humans (33,34). Although the
region is conserved, several ancestral rearrangements have led
to changes in gene order, thereby shortening the targeted seg-
ment, resulting in a deletion of 18 protein-encoding genes that
are also deleted in human 22q11.2DS. Despite the deletions
not being completely identical, the Df1/+ mice have been
found to recapitulate cognitive and behavioural abnormalities
(35,36) and share developmental defects featured in human
22q11.2DS such as cardiovascular abnormalities, although no
thymic or gross skeletal abnormalities such as cleft palate
have been observed (37). Importantly, these mice also suffer
from chronic OM at high incidence, leading to hearing loss
(38), and as such are excellent models for studying the mechan-
isms behind the increased genetic susceptibility to ear disease
in 22q11.2DS patients.
The chromosomally engineered Df1/+ mouse is therefore a
good model for the human syndrome and provided the oppor-
tunity for gene targeting and transgenic complementation ex-
periments. Such complementation studies using bacterial
artiﬁcial chromosome mice overexpressing human transgenes
have narrowed down the candidate genes within the multigene
deletion and highlighted the importance of the T-box transcrip-
tion factor 1 (Tbx1) (39). Heterozygous loss of Tbx1 results in
major structural abnormalities of the heart similar to those ob-
served in Df1/+ mice (39,40), and chronic OM has been reported
(41). The susceptibility to ear disease in 22q11.2DS patients is
therefore likely to be speciﬁcally caused by the reduced expres-
sion of Tbx1.
Owing to the high incidence and impact of OM in children glo-
bally a number of geneticallymodiﬁedmousemutants have been
identiﬁed to unravel the genetic factors that drive the develop-
ment of OM. The use of mouse models to study the pathobiology
of OMhas beenwell established in recent years. Mice that display
a chronic inﬂammation can be categorized as syndromic, non-
syndromic, phenotype- or genotype-driven mouse mutants
(42). The pathogenesis of OM is multifactorial in mousemutants,
including defects in host defence (43–45) and the mucociliary
system of the mucosa lining the middle ear cavity (46–48). The
identiﬁcation of a number of mouse mutants with altered ET
morphology and angle have also revealed clearance as a contrib-
uting factor to the development of OME. These include the non-
syndromic Eya-4 knockout (49), the genotype-driven Tail-short
mouse (50), the syndromic Sh3pxd2b (51), Chd7 knockout (52)
and the Lmna heterozygous mouse (53). In addition, mild cranio-
facial abnormalities as well as a narrowed ET have been sug-
gested to contribute to OM development in heterozygous Jeff
mice (Fbxo11+/−) (54,55). Fbxo11 might also be a candidate gene
for human OM, because association screens in families with
high OM risk have found SNPs in the human FBXO11 gene (56),
further highlighting the importance of murine models in the
translation to human diseases (57). In all of these cases, the
chronic OME is predominantly bilateral. Interestingly, however,
studies in children where the angle and length of the ET was
measured failed to ﬁnd a difference between infants with
and without OME (31), indicating that other factors are likely to
be involved. Therefore, the question remains whether ET anom-
alies underlie OM susceptibility in both syndromic and non-
syndromic populations and mouse models.
To understand themechanisms behind the high susceptibil-
ity to OME in 22q11DSmousemodels, we investigated the devel-
opment of the middle ear and onset of OM in Df1/+ and Tbx1+/−
heterozygous mice. In contrast to the OM mouse models men-
tioned earlier (such as Eya4/+ and Jf/+), OME in Df1/+ mice has
been shown to be frequently unilateral (38). This therefore pro-
vides an excellent opportunity for within-animal controls to
tease apart why one earmight develop OMEwhereas the contra-
lateral ear appears unaffected. The OM in Df1/+ and Tbx1+/− het-
erozygous mice is independent of a palate defect, indicating
that in patients with 22q11.2DS, the ear disease is not caused
primarily by the associated palatal defects. This observation
ﬁts with ﬁndings that the incidence of chronic OM in
22q11.2DS patients is not associated with the type of palatal ab-
normality (12).
Tbx1 is expressed during development in several tissues later
associated with the middle ear. From E8.0 onwards, Tbx1 is ex-
pressed in the endodermal lining of the ﬁrst pharyngeal pouch,
which gives rise to the ET and parts of the epithelium lining the
MEC (58–60). In addition, Tbx1 is expressed in the mesodermal
core of the arches, which give rise to the muscles of the face
(61). Complete loss of Tbx1 in homozygous mutant mice (Tbx1−/−)
leads to a hypoplastic pharynx, missing ET and malformed or
missing ear structures (40,59,62). The heterozygous animals,
however, have been reported as being phenotypically normal
with regards to these tissues (63).
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In this paper, we investigate the development of the middle
ear and ET in Df1/+ and Tbx1+/− mice, focusing on the tissues
that express Tbx1 at earlier stages of development. From our ana-
lysis, we have identiﬁed key defects in the developing tissues of
the mouse mutants and have isolated the cause of the unilateral
incidence of OME. Importantly, we highlight a cause of suscepti-
bility to chronic OM not previously identiﬁed in mouse models,
which will provide crucial information to aid the treatment of
22q11.2DS patients with chronic ear disease.
Results
Otitis media in Tbx1+/− mice resembles that observed
in Df1/+ mice
As previously described, Tbx1+/− mice develop OME (41). Histo-
logical analysis (Fig. 1A–C, E and F) and fresh whole-mount pre-
parations of Tbx1+/− auditory bullae (Fig. 1D) revealed that 77%
(10 of 13) of mice [aged postnatal day 18 (P18) to 44 weeks] dis-
played OM. The degree of the inﬂammation and quantity of effu-
sion with inﬁltrated cells in these mice was very similar to that
previously reported in Df1/+mice (38). The inﬂammation was ob-
served to be either uni- (5 of 10) or bilateral (5 of 10), with no left or
right prevalence in unilateral cases.
OM was found in Tbx1+/− mice as early as P18 (4 of 6), with
spots of effusion and few inﬁltrated cells being the ﬁrst sign of
the disease (Fig. 1B and E). The epithelium in P18 Tbx1+/− mice
at the onset of OM was thin and almost indistinguishable from
themucosa of wild-type (WT, +/+) littermates (Fig. 1, arrowheads
in A and B). In contrast at P26, the Tbx1+/−mice showed more se-
vere degrees of OM (Fig. 1C) categorized by proliferative changes
in themucosal lining of themiddle ear cavity, effusion with inﬁl-
trated cells, increase in mucus-producing goblet cells and capil-
lary hyperplasia (Fig. 1F). The morphological changes of the
middle ear epithelium in older mice were therefore secondary
to the inﬂammation rather than a primary cause.
Normal Eustachian tube morphology and angles in
Df1/+ mice
As anatomical defects of the ET are themost common factors as-
sociated with OM development in human and murine disease
models, we performed 3D reconstructions of the ET from histo-
logical sections. The reconstructed ET with its associated cartil-
age was analysed from the nasopharynx to its incision point
into themiddle ear cavity (Fig. 2A andB). A set of adult littermates
(ﬁve Df1/+ and one WT) was used to analyse differences in size,
shape and localization of the tube. Out of these animals, four
Df1/+ mice presented with unilateral OM and varying degrees of
severity of the inﬂammation, making them within-animal con-
trols for the experiment in addition to a WT littermate control.
Comparing the anatomy, shape and middle ear cavity oriﬁce of
the ET within Df1/+ mice with unilateral OM as well as to a WT
control, we did not observe any gross abnormalities.
In addition, measurements of ET angles were performed
usingmicro-computerized tomography (microCT) scans of skulls
from mice between the ages of 3.5 and 18.5 weeks (WT = 5,
Figure 1. High incidence of OM in Tbx1+/− mice. (A) Wild-type (+/+), (B–F) Tbx1+/−. (A–C, E and F) Frontal trichrome-stained sections of middle ear cavities and (D) freshly
dissected whole-mount preparations of auditory bullae showing the intact tympanic membrane and manubrium of the malleus (dotted line). (A) At P18, the malleus
(arrow) is freely suspended in an air-ﬁlled middle ear cavity. A thin mucosa is lining the middle ear in both WT (A, arrowhead) and P18 Tbx1+/− littermate (B,
arrowhead); however, Tbx1+/− mice frequently displayed patches of effusion with inﬁltrated cells (E, asterisk). (C) At P26, Tbx1+/− mice show a further advanced
inﬂammation with effusion with inﬁltrated cells (F, asterisk), capillary hyperplasia (F, arrow), thickening of the mucosal epithelium and subepithelial connective
tissue (C and F, arrowhead) as well as an increase in mucus-producing cells (F, red arrow). (D) Cloudy effusion with inﬁltrated cells is clearly visible in dissected
auditory bullae (asterisk) in a 44-weeks-old Tbx1+/− mouse. Dorsal is top. Scale bars: A–D, 500 µm; E and F, 100 µm.
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Df1/+ = 8). The midline of the skull was used as a reference point
to measure the angles to the bony oriﬁce of the ET that connects
to the MEC (Fig. 2C), resulting in two angle measurements per
animal. Comparing WT angles with those of Df1/+ mice
(Fig. 2D), no signiﬁcant changes could be found. Using heterozy-
gous Df1/+mice as within-animal controls, we also compared ET
angles of ears without the inﬂammation (n = 10) tomutants exhi-
biting OM (n = 6; Fig. 2E); however, this analysis revealed no sig-
niﬁcant differences.
MicroCT scans were also used to determine morphological
changes of the auditory bulla, the neural crest-derived bony
structure surrounding the middle ear cavity, as reduced auditory
bullae volume has previously been linked to impact on cavitation
of the middle ear (64). Measuring both length and width of the
hollow capsule, we found a signiﬁcant reduction in auditory
bulla size (Supplementary Material, Fig. S1). However, smaller
bulla size did not correlate with incidence of inﬂammation and
no retained mesenchyme was observed in P18 Tbx1+/− mice
with effusion (Fig. 1B and C), indicating that other factors may
cause the high susceptibility to OM.
Df1/+ ears without OM display normal cilia density
and distribution
As OM is often associated with impaired mucociliary clearance,
we examined the ciliary integrity in Df1/+ mice. Scanning elec-
tron microscopy (SEM) have previously revealed that Df1/+ mice
with OM have reduced cilia density, with the cilia rareﬁed and
shortened (38). We therefore wanted to investigate the cilia in
mutant ears without any signs of OM to see whether the cilia
could be a causative factor. In WT and Df1/+ mice without OM,
the mucosa between the ET and cochlea displayed a thick lawn
of evenly distributed cilia (Fig. 3A and B). No difference was ob-
served between the cilia shape and distribution, indicating that
changes in ciliary integrity are secondary to the inﬂammation,
as described in other OM mouse models (65).
Adult Tbx1+/− mice demonstrate an impaired clearing
function of the Eustachian tube
Even though no morphological defects of the ET were evident
from the 3D-reconstructions, and cilia integrity appeared
Figure 2. ET angles and morphology in Df1/+ mice and WT littermates. (A) 3D-reconstruction of the ET (grey) from the nasopharynx (arrow) to the middle ear cavity
(arrowhead) and its associated cartilage (blue) of a 11.5-week-old WT mouse and (B) mutant Df1/+ littermate with OM showing no morphological differences. (C)
Ventral view of a 3D-reconstructed microCT scan of a Df1/+ adult mutant skull with unilateral OM on the right hand side (asterisk), showing no obvious alterations of
the ET angles (red lines) from the middle ear cavity oriﬁce to the midline of the skull (dashed vertical line). (D and E) Measurements of ET angles from 3D-
reconstructed skulls of animals between the ages of 3.5 and 18.5 weeks. (D) No signiﬁcant difference in ET angles comparing Df1/+ mice (n = 16) with control
littermates (n = 10) and (E) Df1/+ mice with clear middle ear cavities (n = 10) to Df1/+ mice with inﬂamed ears (n = 6). Statistical analysis was performed using Mann–
Whitney test, P = 0.4546 and P = 0.5797, respectively.
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normal, the question remained whether the ET of Tbx1+/− mice
was fully functional. We therefore performed a functional ana-
lysis of ET patency to determine whether the ET in Tbx1+/−mice
could clear dye from the middle ear cavity through to the naso-
pharynx and into the oral cavity. For the analysis, we chose ju-
venile mice between the ages of P18 and P21 as the middle ear
was completely cavitated, yet the OM had only just initiated
(see Fig. 1B and E). A trial was ﬁrst carried out using P18 WT
mice. A ﬂuorescent dye was injected into the middle ear under
terminal anaesthesia, and the time that the dye took to appear
in the nasopharynx assessed. Fiveminutes after injection of the
ﬂuorescent dye, it was visible through both soft and hard palate
giving the opportunity to trace whether the dye was cleared
from both or only one ear (Fig. 4A and C)(n = 4). When WT mice
were culled 2–3 min after injection of the dye, no dye appeared
in the palate or nasopharynx/pharynx entrance (n = 2). Fivemin-
utes was therefore selected as the time that WT animals were
able to clear dye through their ETs. In total, we analysed three
litters consisting of 16 WT and 7 Tbx1+/− mice. Mice included
in the study were within a set weight range (between 4.7 and
8.8 g), and no signiﬁcant difference in weight was observed be-
tween WT and Tbx1+/− mice or between male and female mice
(one-way ANOVA, P = 0.0954). In 88% of WT animals, the dye
was cleared from the cavity and appeared in the palate and
pharynx region 5 min after the injection (Fig. 4B). In contrast,
after the same time interval, the dye was found in the pharyn-
geal region in only 14% of Tbx1+/− mice. In the other Tbx1+/−
mice, the dye was either not cleared at all (43%) or only visible
on one side of the palate (43%; Fig. 4D), indicating impairment
of and higher variability in the clearing ability of the ET in
Tbx1+/− mice.
Adult Df1/+ mice have hypoplastic Eustachian tube
muscles
Having ruled out amorphological defect of the ET but yet observ-
ing an impaired ET patency, we turned to analysing ET-asso-
ciated muscles. Tbx1 is expressed in the mesodermal core of
the pharyngeal arches during development (66,67). At E12.5,
Tbx1 is expressed in the mesoderm that gives rise to the muscles
of the ET (Fig. 5A). Thismusclemass includes the ﬁrst pharyngeal
arch-derived medial pterygoid and tensor veli palatini muscle
(mTVP) as well as the fourth pharyngeal arch-derived levator
veli palatini muscle (mLVP) (68–71). Tbx1 has been shown to
regulate the onset of branchiomeric myogenesis by activation
of myogenic regulation factors (MRFs), with MyoD expression
overlapping with Tbx1 (Fig. 5A and B). Muscle masses derived
from the ﬁrst and second pharyngeal arches have been shown
to bemissing in Tbx1−/−mice (72), whereas the fourth pharyngeal
arch was absent (40). The muscles in the Tbx1+/− mice, however,
have been reported to be normal (72).
We examined the mLVP in adult mice heterozygous for the
multigene deletion (Df1/+) and Tbx1 (Tbx1+/−). Histological ana-
lysis of serial sections from the nasopharynx to the middle ear
cavity showed that the mLVP was present in both WT and Df1/+
mice (Fig. 6A and B, respectively, yellow), running inferior to the
ET along its distal axis (Fig. 6A arrow). No differences were found
in either the muscle insertion point into the midline of the soft
palate or the general fascicle direction; however, the mLVP
appeared smaller in size. To conﬁrm this observation, the
whole mLVP was analysed using ImageJ and PRISM GraphPad
to calculate the muscle volume, which revealed a signiﬁcantly
smaller muscle size in adult Df1/+ mice compared with their
WT littermates (Fig. 6C).
Early onset of muscle defect in both Df1/+ and Tbx1+/−
neonatal mice
The observation that adult Df1/+ mice have smaller ET-asso-
ciated muscles raises the question of whether hypoplastic mus-
cles are secondary to the chronic inﬂammation of the middle ear
or caused by a myogenic defect in early development that re-
duces muscle size before the onset of the disease in the uncavi-
tatedmiddle ear.We therefore performed immunostaining using
an antibody against the skeletal muscle marker 12/101 in new-
born mice, which labelled individual muscle fascicles of the
mLVP inferior to the ET and next to the nasopharynx. The num-
ber of fascicles and the general size of the muscle appeared re-
duced in Df1/+mice compared withWT littermates (Fig. 7B and A,
respectively). Muscle measurements were performed as men-
tioned before using histologically stained frontal serial sections,
revealing a signiﬁcant reduction in volume of the mLVP in neo-
natal Df1/+mice (Fig. 7E). The same signiﬁcantly smaller volume
of the mLVP was also found in P1 Tbx1+/− mice using Masson’s
Figure 3.Df1/+ ears without OM display normal cilia density and distribution. (A) 17-week-oldWTmouse. The epithelium adjacent to the ET and cochlea is highly ciliated
with patches of unciliated epithelium. (B) 38-week-old Df1/+mutant without OM. The epithelium shows a similar ciliary integrity despite the old age of this mouse. Scale
bar: 10 µm.
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Trichrome-stained histological sections (Fig. 7C, D and F). To in-
vestigate the onset of the defect, we compared myogenesis in
Tbx1+/− and WT embryos at E15.5. This is the ﬁrst time point
when the mLVP can be distinguished from the other neighbour-
ingmuscles, with themuscle precursors at earlier stages forming
a combined mass (Fig. 5B and C). MyoD staining showed a subtle
Figure 4. Functional test of ET patency in adult Tbx1+/−mice. (A andC)WT (+/+); (D) Tbx1+/−. (A) Ventral view of the soft palate (SP) and hard palate (HP) withﬂuorescent dye
visible in the nasopharynx to pharynx opening (arrow). Right is frontal. (C) SameWTanimal as (A) with ﬂuorescent dye (indicated by the asterisk) visible on both left hand
side (LHS) and right hand side (RHS) of the palatal midline (dashed white line). (D) In Tbx1+/−mice, the dye was frequently observed only on one side, here the LHS of the
palate (asterisk). (B) Column graph displaying the percentage of animals with different dye clearing efﬁciency of the ET, classiﬁed as no dye in pharynx (black), dye only on
one side of the soft palate (grey) and dye in the pharynx (white). Analysedwere 3 litters between the ages of P18 and P21. Fiveminutes after the dye injection, we observed
88% (14 of 16) ofWTmicewith and 12% (2 of 16) without dye in the pharynx region. In contrast, theminority of Tbx1+/−mice (14%, 1 of 7) showed dye in the pharynx. 43% (3
of 7) either presented with no dye or unilateral dye on the right (1 of 3) or left (2 of 3) hand side of the palate. Scale bar: A, C, D 1 mm.
Figure 5. Embryonic expression of Tbx1 and MyoD in ET muscles. (A–C) WT (+/+); (D) Tbx1+/−. (A) At E12.5, Tbx1 is expressed in the early ET (arrowhead) and adjacent
branchiomeric muscle masses (arrow). Note Tbx1 is also expressed in forming tongue muscles (asterisk). (B) The same ET muscle masses express the MRF MyoD
(arrow). (C) At E15.5, MyoD is expressed in muscle ﬁbres of the maturing mLVP (arrowheads) next to the nasopharynx (NP) and ET, whereas in Tbx1+/−, MyoD appears to
be diffusely expressed (arrowheads). Scale bars: 200 µm.
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difference in the developingmLVPat this time point, with theWT
muscle appearing as a thin band of ﬁbres whereas the Tbx1+/−
mLVP was more diffuse without an obvious orientation (Fig. 5C
and D). These results indicate that Tbx1 is the primary gene re-
sponsible for the myogenic defect, which is evident as soon as
the mLVP can be detected.
Interestingly, when assessing themLVP volume on either side
of the head within the same animal, we frequently found a sig-
niﬁcant difference in severity of the defect in the Tbx1+/− mice.
In WT mice, when the muscle volume on one side was divided
by the other side, the ratio equalled 1, indicating symmetry. How-
ever, in the Tbx1+/− mice, when the ratio was compared (bigger
muscle divided by smaller muscle), a clear asymmetry within
the same animal was observed (Fig. 7G).
Asymmetry and smaller muscle size in juvenile Tbx1+/−
mice correlates with the development of Otitis media
The variation in mLVP volume across and within the Tbx1+/− and
Df1/+ population could explain the observed variation in suscepti-
bility to OM. We therefore assessed the muscle volume in Tbx1+/−
mice and correlated the muscle size to the presence of uni- or
bilateral OM. The onset of OM, as shown by patches of effusion
with a few inﬁltrated cells, was observed as early as P18 (Fig. 1B
and E), and so this stagewas chosen for the analysis. As expected,
comparing the overall muscle size of themLVP inWTwith Tbx1+/−
littermates,we founda signiﬁcant reduction in themLVPofTbx1+/−
mice (Fig. 8A). To assess whether the muscles in the vicinity of
the ETwere hypoplastic, we also examined the ﬁrst arch-derived
tensor tympani muscle (mTT), which originates from the anter-
ior tubal cartilage and runs posterior-laterally along the ET before
entering themiddle ear cavity. Interestingly, thismusclewas also
signiﬁcantly reduced in size, however, to a lesser degree then the
mLVP in the same animals, indicating not all muscles are af-
fected to the same extent (Supplementary Material, Fig. S2 and
Table S1).
We then correlated the mLVP volume to inﬂamed and unin-
ﬂamed ears in the mutant mouse population with either uni-
or bilateral OMand found that themLVPwas signiﬁcantly smaller
in inﬂamed ears comparedwith ears without OM, demonstrating
a direct correlation betweenmLVPmuscle size and development
of the disease (Fig. 8B; Supplementary Material, Table S1).
Importantly, a similar correlation was not observed when the
neighbouring, non-ET muscle (the mTT) was assessed. There-
fore, the link between ear disease and muscle volume appears
to be only valid for the ET muscles (Supplementary Material,
Fig. S2 and Table S1).
Discussion
Here, we present a novel mechanism by which reduced Tbx1 ex-
pression leads to either uni- or bilateral incidence of OM. Using
mousemodels, we show that changes to the size of a key ETmus-
cle, the levator veli palatini (73), during development impact on
the ability of the ET to clear debris and secretions from themiddle
ear after birth, resulting in increased susceptibility to developing
OME.
ET function is regulated by two paratubalmuscles, which con-
tract in a sequentialmanner, thereby allowing a discrete air bolus
to travel through the ET into the MEC (68). The speciﬁc contribu-
tions of the paratubal muscles are controversial (69,74). Recent
advances suggest that the ﬁrst arch-derived tensor veli palatini
muscle opens the posterior portion of the ET, whereas the fourth
pharyngeal arch-derived levator veli palatini muscle functions in
opening and closing of the anterior pharyngeal portion (68,75).
Myogenic defects in the mLVP have been implicated in tubal
dysfunction in humans and are likely to increase the risk of OM
development (73).
Tbx1 is expressed in the mesodermal core of the pharyngeal
arches from as early as E9.5 (59). Previous studies have shown
that head muscles, derived from pharyngeal arch mesoderm,
are hypoplastic or missing when Tbx1 is homozygously deleted.
The phenotype has been attributed to increased apoptosis,
which reduces the muscle precursor pool in the mesodermal
core, and an impaired activation of MRF genes during myogen-
esis. In heterozygous mice, however, analysis of the ﬁrst and se-
cond pharyngeal arch muscles showed no alteration in muscle
size (41,72), indicating that thesemuscles are able to develop cor-
rectly with half the normal dose of Tbx1.
In this study,we concentrated on intrinsic ETmuscles derived
from caudal arches, instead of cranial arches. We performed
volumetric measurements of the fourth arch-derived levator
veli palatini muscle in Tbx1+/− and Df1/+ mice. Volumetric ana-
lysis is a much more sensitive method to gauge size compared
with the use of histological sections or whole-mount prepara-
tions. Hypoplastic muscles were observed in 100% of mutants
Figure 6.Muscle involved in ET opening is hypoplastic in adultDf1/+mice. (A and B) Trichrome-stained frontal sections of the (A) nasopharynx (NP) and frontal portion of
the ET (arrow) showing the levator veli palatini (mLVP, yellow) and Palatopharyngeus muscle (mPP, purple) inserting into the soft palate (SP) in 11.5-week-old control
littermates. (B) Df1/+ mice show a reduction in muscle size. (C) Measurements of the mLVP (yellow) volume from histological frontal sections show that muscles in
adult Df1/+ animals (n = 8) are signiﬁcantly smaller compared with those of control littermates (n = 2; P < 0.0444). Statistical analysis was performed using non-
parametric Mann–Whitney test. Scale bars: A and B, 200 µm.
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examined, ranging from adult 11.5-week-old mice presenting
with severe inﬂammations to E18.5 embryos with uncavitated
ears, indicating that a reduction ofmuscle sizewas not a second-
ary consequence of the disease. A defect in the expression do-
main of MyoD was also apparent at E15.5, when the mLVP is
ﬁrst identiﬁable as a distinct muscle. Subtle changes in the ex-
pression ofMyoD therefore appear to underlie the eventual smal-
ler size of this muscle.
Themost caudal and ventral structures in the developing em-
bryo show the strongest expression of Tbx1 (61,62,76). Tbx1 also
functions during pharyngeal segmentation, which has been es-
tablished by timed mutation and cell-fate mapping experiments
and is expressed in a rostro-caudal gradient following the
direction of pharyngeal segmentation (59,77). As such, ablation
of Tbx1 results in an unsegmented pharynx and the absence of
PP2–4 and PA3–6, with PA2 being hypoplastic and PA1 present
but abnormally patterned (40,72). Taken together, more caudal
arches (PA3–PA6) seem to be more severely affected than cranial
regions. The observation is underlined by other phenotypes
being more penetrant in caudal arches, such as neural crest cell
abnormalities. Tbx1 expressed in the surface ectoderm acts up-
stream of the homeobox gene Gastrulation brain homeobox
(Gbx2), which is required for normal pharyngeal arch artery de-
velopment by providing directional cues to cardiac NCCs to
Figure 7. Neonatal Df1/+ and Tbx1+/− mice have hypoplastic mLVP. (A and C) WT; (B) Df1/+; (D) Tbx1+/−. The mLVP is outlined in white. (A and B) Immunohistochemistry
against the skeletalmusclemarker 12/101 stains themuscle fascicles of themLVP in newborn controlmice (A) and inDf1/+ littermates, showing a reducedmuscle fascicle
number. (D) A reduced muscle size can also be found in Masson’s Trichrome-stained Tbx1+/−mice compared with (C) control littermates. (E and F) Measurements of the
mLVP show that muscle masses in neonatal Df1/+ (n = 4, E) and Tbx1+/− (n = 6, F) animals are signiﬁcantly smaller compared with their control littermates (WT = 4 and
WT = 6, respectively; P = 0.0286 and 0.0022, respectively). (G) Scatter plot graph displaying the ratio of the two mLVP within each animal, demonstrating a signiﬁcant
size difference between these muscles in neonatal Tbx1+/− mice (WT = 6, Tbx1+/− = 6; P = 0.0411). Statistical analysis was performed using non-parametric Mann–
Whitney test. Neonatal ages were ranging between E18.5 and P1. Note accumulated blood in the nasopharynx (NP; A, asterisk) occurred post-mortem. Scale bars: A
and B, 100 µm; C and D, 200 µm.
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migrate into caudal arches (78). In the absence of Gbx2, NCC mi-
gration into PA3, 4 and 6 is altered, leading to defective 4PAA de-
velopment, a hallmark feature of 22q11.2DS patients (78). Cranial
nerves are partly derived from NCCs and display abnormal mi-
gratory pathways and fusion in Tbx1−/− mice, including the
most rostral (trigeminal and facial) and more caudal (glossopha-
ryngeal and vagus) nerves (59). In mice heterozygous for Tbx1,
ganglia fusion has only been observed for the most caudal
nerves, indicating that caudal arches are more sensitive to al-
tered Tbx1 dose than rostral pharyngeal structures (79). Other
temporal-spatial signals have been implicated in pharyngeal pat-
terning such as the retinoic acid (RA) signalling pathway. Even
subtle disruptions of this pathway by either decreased or in-
creased expression of genes involved in RA metabolism have
been shown to be detrimental to caudal arch development and
result in 22q11.2DS-like defects (80). Tbx1 has been linked to the
RA pathway because RA-degrading enzymes, such as CYP26A1,
have been shown to be downregulated in microarray studies of
Df1/+;Tbx1+/− transheterozygotes (81). Interestingly, expression
studies also indicate that Cyp26a1 is reduced in Tbx1+/− mice
(80), suggesting that inmicewith half the dose of Tbx1, the devel-
opment of the caudal pharyngeal apparatus is also particularly
sensitive to altered Tbx1 dose. Our analysis of muscle volume
also indicates that rostral muscles are less affected compared
with more caudally derived muscles, with a much smaller
mLVP (fourth arch) compared with the mTT (ﬁrst arch), agreeing
with ﬁndings that half the dose of Tbx1 ismore likely to cause de-
fects in tissues and organs derived from caudal arches rather
than rostral arches (40,66,79). However, we did observe a signiﬁ-
cant reduction in size of themTT, indicating that all cranial mus-
cles are inﬂuenced by Tbx1 dosage.
Although all heterozygousmutants had hypoplastic muscles,
the degree of hypoplasia differed not only between littermates
but also between ears within the same animal (contralateral
sides) and between different muscles. The variability in mLVP
muscle volumewas directly correlated with unilateral OM, show-
ing that the side presenting with inﬂammation was associated
with signiﬁcantly smaller ET muscles than the contralateral
unaffected ear. The results were signiﬁcant despite using only a
small data set. The same correlation was not found for the mTT.
This muscle is attached to the manubrium and protects the ear
against loud noises, and despite running along the ET has no
functional implication in ET opening and closing. Although re-
duced in size, the mTT was not signiﬁcantly smaller in inﬂamed
ears compared with uninﬂamed ears (Supplementary Material,
Fig. S2). This data indicate that high susceptibility to ear disease
is linked to defects in ET muscles speciﬁcally, rather than owing
to a general muscle hypotonia.
In Tbx1−/− mice, sporadic and hypoplastic muscles display
normal patterning, proliferation and differentiation properties
once determined, indicating that Tbx1 is not absolutely required
for MRF activation but initiates their expression in a robust and
bilateral manner (72). The observed asymmetry in both homozy-
gous and heterozygous mutants might therefore underlie a sto-
chastic mechanism in premyoblast speciﬁcation.
Interestingly, we found that some of the Tbx1 heterozygotes
were able to successfully clear dye from the middle ear into the
pharynx on one side of thehead but not the other. Such unilateral
clearancewas not observed in any of theWTmicewe tested. The
asymmetry in muscle volume between both ET muscles within
Tbx1+/− mice underlines the dosage-dependent role of Tbx1 in
the robust and bilateral activation of MRF genes during myogen-
esis of pharyngeal arch-derived muscles (72).
Whether the condition of the hypoplastic levator veli palatini
muscle is responsible for an insufﬁcient clearance of the ET
owing toweaker contraction and strength or whether themuscle
produces defects in the elevation of the soft palate which then
obstructs the opening and closing of the tube remains unclear.
However, the ET functional tests imply a direct inﬂuence of the
muscle on ET patency.
Other common causes of the inﬂammation such as defects in
the mucociliary clearing apparatus contributing to the develop-
ment of OM cannot be excluded; however, SEM of adult Df1/+
mice without OM showed normal cilia morphology and distribu-
tion. In addition, 22q11.2DS mouse models are not reported to
have a cilia defects and do not display any phenotypes normally
associated with immotile cilia such as situs inversus or infertility,
indicating that half the dose of Tbx1 is sufﬁcient for normal cilia
function.
This is the ﬁrst OMmouse model to link a myogenic defect to
the development of inﬂammation. Previous models have impli-
cated defects in the angle or morphology of the ET itself
(49,52,53,55). Our ﬁndings suggest new strategies for treatment
and particularly prevention of the inﬂammation in susceptible
individuals. Currently, OM is mainly treated by the insertion of
ventilation tubes into the tympanicmembrane to help drain effu-
sions from the middle ear cavity. This is not only the most com-
mon operation in the UK (82) but also entails complications such
as tympanic membrane perforation, atrophy and the develop-
ment of cholesteatomas (83).
As the size of the ET muscles appears to be a crucial factor in
OM development in both Tbx1+/− andDf1/+mice, we hypothesize
that in 22q11.2DS patients targeted training of speciﬁc muscle
masses associated with the ET and soft palate might reduce sus-
ceptibility to the disease. We therefore suggest more trials on al-
ternative treatments, such as ET rehabilitation therapy. This is a
controversial trainingmethod for lessening symptoms of ET dys-
function by exercising paratubal muscles (84) andmight serve as
an alternative non-invasive therapy for 22q11.2DS patients. Cur-
rently, there is only limited data available on trials regarding the
speciﬁc training of head and neck muscle groups. In the case of
decreased respiratory abilities, however, exercise of ventilatory
Figure 8.mLVPvolume is signiﬁcantly reduced in inﬂamed ears of juvenile Tbx1+/−
mice. (A) Comparison ofmLVP volume inWT (n = 4) and Tbx1+/− (n = 10) littermates
showed a signiﬁcant reduction of muscle size in mutant mice (P = 0.002). (B)
Boxplot graph displaying correlation between muscle volume and early signs of
the inﬂammation within Tbx1+/− animals. Muscles in inﬂamed ears (n = 4) were
signiﬁcantly smaller than the muscles in ears without signs of an inﬂammation
(n = 4; P = 0.0286). Statistical analysis was performed using non-parametric Mann–
Whitney test. One animal was excluded from the analysis because of inﬁltrated
blood cells that occurred post-mortem.
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muscles has proven a successful therapy, resulting in a rapid im-
provement of muscle strength and swallowing performance (85).
Alternatively, auto-inﬂation of the ET may present a possible
method for treating OM.
We have shown that subtle developmental defects in the ex-
pression ofMyoD and later the size ofmuscle populations derived
from the fourth pharyngeal arch can lead to later susceptibility to
OM. Although our work here focuses on the role of Tbx1, other
genes with roles in early muscle initiation and speciﬁcation
may also lead to similar increased susceptibility. For example,
Eya1 and its cofactor Six1 are downregulated in caudal arches of
Tbx1−/− mice and recapitulate most 22q11.2DS features when
homozygously deleted (86). Eya1 is expressed in themesodermal
core during earlymuscle development and in adult skeletalmus-
cles (87). In addition, patients with mutations in EYA1 have vari-
ous ear defects including high susceptibility to OM (88,89). Six1−/−;
Eya1−/− mice have severely hypoplastic branchiomeric muscles
(86), suggesting an additional role of these genes in branchio-
meric myogenesis. Ectopic expression of the transcriptional
complex has been shown to reprogram adult skeletal muscles
by inducing a ﬁbre type transition from the slow (type I) to the
fast type (type II) (87). Zim et al. (90) examined another fourth
arch-derived muscle, the pharyngeal constrictor muscle in
human 22q11.2DS patients, revealing an increase in ﬁbre type I,
suggesting that Tbx1 might impact on muscle ﬁbre type. How-
ever, no changes in the ﬁbre composition were found in themas-
seter and pharyngeal constrictor in Tbx1+/− mice (91). As the
levator veli palatini muscle and tensor veli palatini muscle are
predominantly composed of ﬁbre type I, a muscle ﬁbre-related
contribution to muscle hypotonia in mutant mice appears un-
likely, suggesting that the main cause for the impaired clearing
function in Tbx1+/− and Df1/+ mice is muscle hypoplasia owing
to smallermuscle size. This is also highlighted by the observation
that the caudal arch-derived pharyngeal constrictor muscle
was shown to be signiﬁcantly thinner in 22q11.2DS patients
(90), indicating that muscle masses derived from caudal arches
are generally smaller.
Material and Methods
Animals
The generation of Df1/+ and Tbx1+/− mutant mice has been de-
scribed (37,66). In brief, both lines had been maintained on a
C57BL/6 background for a minimum of 10 generations prior to
the analyses. The deletion itself was engineered on a 129S5
SvEvBrd genetic background. Mice were housed in groups in
Home Ofﬁce-approved conditions, which did not increase sus-
ceptibility to infections in control mice.
Middle ear histology and staining
Mouse heads were ﬁxed overnight in 4% paraformaldehyde (PFA)
at 4°C and then, depending on the age, decalciﬁed in EDTA Solu-
tion [67.5% EDTA, 7.5% PBS and 25% PFA (4%)]. The tissuewas de-
hydrated through amethanol series and isopropanol and cleared
in tetrahydronaphthalene before embedding in parafﬁnwax. The
9-μm frontal sections were mounted on Superfrost Plus Slides,
dewaxed in Histoclear and rehydrated through IMS.
For Trichrome staining, the slideswere stainedwith 1%Alcian
blue in 3% acetic acid pH 2.5, Ehrlich’s haematoxylin and 0.5% Sir-
ius Red in saturated picric acid.
For muscle measurements, Masson’s Trichrome staining was
used to distinguish muscle (red) and cells from surrounding
connective tissue and collagen ﬁbres (blue). The slides were incu-
bated in Weigert’s Haematoxylin, stained in running water and
Masson’s Stain, differentiated in 5% Phosphomolybdic/5%
Phosphotungstic Acid and immersed in 1% acetic acid. For both
stainingmethods, slides were then dehydrated, incubated in His-
toclear and mounted in Neo-Mount. Slides were viewed and
photographed under bright ﬁeld using a Nikon Digital Sight
Camera.
For whole-mount dissections, mice were culled by cervical
dislocation and the auditory bulla was carefully dissected by re-
moving the outer ear, leaving the tympanic membrane intact.
Pictures were taken with a dissection microscope (Leica MZFiii)
and Leica DFC300 camera.
Scanning electron microscopy
Themiddle ears of adult mice were dissected and the middle ear
mucosa exposed by removing the outer ear, eardrum, tympanic
ring and the malleus and incus. Ears were then ﬁxed in 2.5% glu-
taraldehyde in 0.15  cacodylate buffer (pH 7.2) overnight at 4°C
and washed and post-ﬁxed in 1% osmium tetroxide. Specimens
were then dehydrated through an ethanol series and dried
using a Polaron E3000 critical point dryer. After mounting and
coating with gold (Emitech K550X sputter coater), the surface of
the mucosa was examined and images recorded using a Hitachi
S-3500N scanning electron microscope operating at 10 kV in
high vacuum mode.
Immunohistochemistry
Slides were deparafﬁnized, rehydrated to PBS and incubated in
Tris–EDTA Buffer, pH 9 for 30 min at 95°C for heat-induced anti-
gen retrieval. Sections were permeabilized in 1% Triton X-100 in
PBS and blocked in Blocking Solution (10% goat serum and 1%
BSA in PBT) for 1 h at room temperature before incubation in
the primary antibody 12/101 (DSHB, mouse, 1 : 100) overnight at
4°C. The secondary antibodyAlexa Fluor 488 anti-mouse (Invitro-
gen) was diluted 1 : 500 in Blocking Solution and incubated for 2 h
at room temperature. After washing in PBS, the slides were
mounted using Vectashield mounting medium. Slides were
photographed with an Axioscop 2 plus microscope (Axio Cam
HRc).
In-situ hybridization on parafﬁn slides
Digoxigenin-labelled RNA antisense probes for Tbx1 and MyoD
were prepared by standard methods. The probes used for Tbx1
(61) andMyoD (92) were all previously described. In-situhybridiza-
tion on frontal sections was performed according to previously
published methods (93).
Muscle measurements
Measurement of the levator veli palatini muscle was performed
from histologically stained serial sections using Image J. Mea-
surements taken from either every (neonatal mice) or every se-
cond slide (P18 and older mice) were interpolated using a
fourth-order polynomial regression model created in PRISM
GraphPad. The area under the curve represented the precise
volume of themuscles andwas therefore used for statistical ana-
lysis. All muscle measurements were analysed using a Student’s
t-test. A non-parametric Mann–Whitney test was also signiﬁcant
when applied to the obtained measurements.
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3D reconstruction of the Eustachian tube
Serial histologically stained sections were used for 3D recon-
struction. A digital picture of the ET from the nasopharynx to
the middle ear cavity was taken for each ear of every other sec-
tion. To contour the area of interest and to generate the 3D sur-
face of the ET, WinSurf Software was used. Alignment of the
stack was performed by eye, andmeasurements were performed
in Image J.
Micro-computerized tomography
MicroCT was used for the 3D analysis of Df1/+ and WT skulls.
Adult mouse heads were ﬁxed in 4% PFA over night at 4°C. After
washing in PBS, they were scanned using a GE Locus SP micro
scanner (GE Pre-clinical Imaging, London, Ontario, Canada).
Auditory bulla size and angle measurements of the ET were per-
formed using MicroCT images, MicroView Program and Image J.
Functional test of the Eustachian tube
Postnatal day 18 (P18) and P21 old mice were terminally sedated
using a 1 : 2:1 solution of fentanyl citrate and ﬂuanisone anaes-
thesia (Hypnorm, VetaPharma), ddH2O and midazolam hydro-
chloride (Hypnovel, Roche) at a dosage of 5 µl per 1 g. After
sedation occurred, the tympanic membrane was carefully punc-
tured and mice were injected with a 1% aqueous solution of the
ﬂuorescent tracer Fluorescein (Sigma) into both middle ear cav-
ities and left in a prone position. Micewere culled by cervical dis-
location after a validated time of 5 min. To visualize the soft
palate and nasopharynx to pharynx oriﬁce, the mandible and
tongue were dissected and photographed in a supine position
to allow a ventral view of the palate using a dissection micro-
scope (Leica MZFiii) and Leica DFC300 camera with ﬂuorescence.
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